韩国社区70岁及以上老年人肌少症患病率:AWGS 2019筛查与诊断工具的应用
该横断面研究基于韩国全国衰弱与老龄化队列(KFACS),纳入2123名70-84岁社区居住老年人,采用亚洲肌少症工作组(AWGS)2019定义和算法评估肌少症患病率。结果示可能肌少症患病率男性20.1%、女性29.2%,肌少症患病率男性21.3%、女性13.8%,严重肌少症男性6.4%、女性3.2%。AWGS 2019诊断的肌少症患病率显著高于AWGS 2014。
要点
- 社区70-84岁老年人中,AWGS 2019定义的可能肌少症患病率男性20.1%、女性29.2%。
- AWGS 2019诊断的肌少症患病率男性21.3%、女性13.8%,显著高于AWGS 2014。
- 用小腿围和SARC-CalF筛查可能肌少症或比单用SARC-F更合适。
核心结论
- 在70-84岁社区居住老年人中,按AWGS 2019算法,使用小腿围和SARC-CalF筛查可能肌少症或比单用SARC-F问卷更合适。
- AWGS 2019标准诊断的肌少症患病率显著高于AWGS 2014标准。
研究设计与样本
- 横断面队列数据分析,来自韩国全国衰弱与老龄化队列研究(KFACS)。
- 共纳入2123名70-84岁可走动社区居住老年人,平均年龄75.9±3.9岁,女性占49.5%。
- 采用双能X线吸收法测量四肢骨骼肌量,并评估握力、步速、5次坐立试验、计时起立-行走试验和简易体能状况量表。
主要发现
- 按AWGS 2019算法,全样本中小腿围、SARC-F和SARC-CalF筛查出的肌少症风险比例分别为43.5%、7.5%和26.0%。
- 可能肌少症(基于3种筛查工具及肌力或体能测试)患病率男性20.1%、女性29.2%。
- 肌少症(低肌肉量加低握力和/或慢步速)患病率按AWGS 2019为男性21.3%、女性13.8%,按AWGS 2014为男性10.3%、女性8.1%。
- 严重肌少症患病率男性6.4%、女性3.2%。
关键数值与推荐
- AWGS 2019算法中小腿围、SARC-F、SARC-CalF筛查风险比例分别为43.5%、7.5%、26.0%。
- 可能肌少症患病率男性20.1%、女性29.2%。
- 肌少症患病率AWGS 2019男性21.3%、女性13.8%,AWGS 2014男性10.3%、女性8.1%。
- 严重肌少症患病率男性6.4%、女性3.2%。
临床怎么用
- 在社区70-84岁老年人肌少症筛查中,可考虑使用小腿围和SARC-CalF替代单用SARC-F问卷。
- 采用AWGS 2019标准评估肌少症时,需注意其患病率显著高于AWGS 2014标准。
局限性
- 原文未报告局限性内容。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To describe the prevalence of sarcopenia in a large group of community-dwelling older adults using the Asian Working Group for Sarcopenia (AWGS) 2019 definition and algorithm. DESIGN: Cross-sectional data analysis of a cohort study. SETTING: The Nationwide Korean Frailty and Aging Cohort Study (KFACS). PARTICIPANTS: A total of 2123 ambulatory community-dwelling older adults, aged 70 to 84 years (mean, 75.9 ± 3.9 years; 49.5% women) were enrolled in the KFACS. METHODS: Appendicular skeletal muscle mass was measured by dual-energy x-ray absorptiometry. Physical function was assessed by handgrip strength, usual gait speed, the 5-times-sit-to-stand test, the timed up-and-go test, and the Short Physical Performance Battery. In a case-finding assessment, screening for sarcopenia was performed using the calf circumference (CC), SARC-F questionnaire, and SARC-F combined with CC (SARC-CalF). RESULTS: According to the AWGS 2019 algorithm, 43.5%, 7.5%, and 26.0% of the subjects in the whole study sample were classified as those at risk for sarcopenia according to CC, SARC-F, and SARC-CalF, respectively. The prevalence rates of possible sarcopenia using 3 screening tools for case-finding and muscle strength or physical performance tests according to the AWGS 2019 diagnostic algorithm were 20.1% in men and 29.2% in women. The prevalence rates of sarcopenia, when defined as low muscle mass plus low handgrip strength and/or slow gait speed, were significantly higher according to the AWGS 2019 (21.3% in men and 13.8% in women) than the AWGS 2014 (10.3% in men and 8.1% in women) definitions. The prevalence of severe sarcopenia was 6.4% in men and 3.2% in women. CONCLUSIONS/IMPLICATIONS: The results of our study suggest that the use of CC and SARC-CalF to screen for possible sarcopenia may be more suited than using the SARC-F questionnaire alone according to the AWGS 2019 diagnostic algorithm in community-dwelling adults aged 70 to 84 years. The prevalence of sarcopenia was significantly higher according to the AWGS 2019 than AWGS 2014 criteria.
引用
- Kim M, Won CW. Sarcopenia in Korean Community-Dwelling Adults Aged 70 Years and Older: Application of Screening and Diagnostic Tools From the Asian Working Group for Sarcopenia 2019 Update. J Am Med Dir Assoc. 2020. PMID: 32386844. doi:10.1016/j.jamda.2020.03.018
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。